Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.43 +0.13 (+10.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) (2017 - 2026)

Updated

Chemomab Therapeutics' Property, Plant & Equipment (Net) came in at $158,000 for Q2 2026, down 27.2% from $217,000 a year earlier and down 5.4% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

At the end of FY2025, Chemomab Therapeutics' Property, Plant & Equipment (Net) was $176,000, down 29.6% from FY2024.

  • Property, Plant & Equipment (Net) has declined in each of the last three years, though with a five-year compound annual growth rate of 3.0% (FY2020 to FY2025).
  • Going back by year, Property, Plant & Equipment (Net) was $250,000 in FY2024 (-17.5%), $303,000 in FY2023 (-17.4%), $367,000 in FY2022 (+2.8%) and $357,000 in FY2021 (+134.9%).
  • The Q2 2026 figure represents the lowest quarterly Property, Plant & Equipment (Net) since Q1 2021.
  • Year-over-year, Property, Plant & Equipment (Net) has declined for 14 consecutive quarters, with an average decline of 23.7% over the last eight quarters.
  • The fastest year-over-year change in Property, Plant & Equipment (Net) over five years came in Q1 2022 (growth of 141.9%), and the weakest in Q4 2025 (a decline of 29.6%).
  • Business Quant data shows CMMB's Property, Plant & Equipment (Net) at $167,000 (Q1 2026), $176,000 (Q4 2025) and $188,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Chemomab Therapeutics 10.28 Mn 10.28 Mn - 158,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 158,000.00
Mar 31, 2026 167,000.00
Dec 31, 2025 176,000.00
Sep 30, 2025 188,000.00
Jun 30, 2025 217,000.00
Mar 31, 2025 237,000.00
Dec 31, 2024 250,000.00
Sep 30, 2024 262,000.00
Jun 30, 2024 276,000.00
Mar 31, 2024 289,000.00
Dec 31, 2023 303,000.00
Sep 30, 2023 319,000.00
Jun 30, 2023 338,000.00
Mar 31, 2023 352,000.00
Dec 31, 2022 367,000.00
Sep 30, 2022 380,000.00
Jun 30, 2022 355,000.00
Mar 31, 2022 358,000.00
Dec 31, 2021 357,000.00
Sep 30, 2021 234,000.00
API Access

Chemomab Therapeutics Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=CMMB&period=max&api_key=YOUR_API_KEY